Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.
Journal: Therapeutic advances in neurological disorders
Published: March 04, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2025
Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications.
Journal: Muscle & nerve
Published: March 25, 2024
Improvement of fatigue in generalised myasthenia gravis with zilucoplan.
Journal: Journal of neurology
Published: December 18, 2023
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Journal: Therapeutic advances in neurological disorders
Published: October 17, 2023
Therapeutic targeting of ALS pathways: Refocusing an incomplete picture.
Journal: Annals of clinical and translational neurology
Published: June 23, 2023
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants.
Journal: Brain : a journal of neurology
Published: February 20, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Journal: The Lancet. Neurology
Published: November 10, 2022
Last Updated: 09/26/2026